Intraoperative Subanesthetic Ketamine Versus Dexmedetomidine Infusion for Prevention of Post-traumatic Stress Disorder After Traumatic Brain Surgeries
NCT ID: NCT06498700
Last Updated: 2024-08-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
52 participants
INTERVENTIONAL
2024-07-15
2025-03-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Stellate Ganglion Block Combined With Dexmedetomidine or Subanesthetic Ketamine Infusion for Treatment of Neurostorm.
NCT06354673
Study on Cerebral Protection of Dexmedetomidine for Patients With Traumatic Brain Injury
NCT04006054
Ketamine Versus Dexmedetomidine for Prevention of Postoperative Delirium
NCT05341154
Monitored Anesthesia Care: Dexmedetomidine-Ketamine Versus Dexmedetomidine- Propofol For Chronic Subdural Hematoma
NCT04621526
Dexmedetomidine-Ketamine Infusion in Breast Surgeries
NCT04048226
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ketamine(K)
0.5 mg/kg/h ketamine infusion
ketamine
0.5 mg/kg/h ketamine infusion
dexmedetomidine(D)
0.1 ug/kg/h dexmedetomidine infusion
dexmedetomidine
0.1 ug/kg/h dexmedetomidine infusion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ketamine
0.5 mg/kg/h ketamine infusion
dexmedetomidine
0.1 ug/kg/h dexmedetomidine infusion
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zagazig University
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marwa Mohamed Medhat
assistant professor of anesthesia and surgical intensive care (Principal Investigator)
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
marwa M Medhat
Role: PRINCIPAL_INVESTIGATOR
Zagazig University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine,Zagazig University
Zagazig, Sharqia Province, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
440
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.